1. Dynamic stem-loop extension by Pol θ and templated insertion during DNA repair.
- Author
-
Carvajal-Maldonado D, Li Y, Returan M, Averill AM, Doublié S, and Wood RD
- Subjects
- Humans, DNA End-Joining Repair, DNA Polymerase beta metabolism, DNA Polymerase beta genetics, DNA Polymerase beta chemistry, DNA Repair, DNA, Single-Stranded metabolism, DNA, Single-Stranded genetics, DNA, Single-Stranded chemistry, Replication Protein A metabolism, Replication Protein A genetics, DNA Polymerase theta, DNA-Directed DNA Polymerase metabolism, DNA-Directed DNA Polymerase genetics
- Abstract
Theta-mediated end joining (TMEJ) is critical for survival of cancer cells when other DNA double-stranded break repair pathways are impaired. Human DNA polymerase theta (Pol θ) can extend ssDNA oligonucleotides, but little is known about preferred substrates and mechanism. We show that Pol θ can extend both ssDNA and RNA substrates by unimolecular stem-loop synthesis initiated by only two 3' terminal base pairs. Given sufficient time, Pol θ uses alternative pairing configurations that greatly expand the repertoire of sequence outcomes. Further primer-template adjustments yield low-fidelity outcomes when the nucleotide pool is imbalanced. Unimolecular stem-loop synthesis competes with bimolecular end joining, even when a longer terminal microhomology for end joining is available. Both reactions are partially suppressed by the ssDNA-binding protein replication protein A. Protein-primer grasp residues that are specific to Pol θ are needed for rapid stem-loop synthesis. The ability to perform stem-loop synthesis from a minimally paired primer is rare among human DNA polymerases, but we show that human DNA polymerases Pol η and Pol λ can catalyze related reactions. Using purified human Pol θ, we reconstituted in vitro TMEJ incorporating an insertion arising from a stem-loop extension. These activities may help explain TMEJ repair events that include inverted repeat sequences., Competing Interests: Conflict of interest R. D. W. owns stock in Repare Therapeutics Inc. The other authors declare that they have no conflicts of interest with the contents of this article., (Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF